| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.21B | 14.66B | 15.24B | 17.57B | 14.47B | 10.67B |
| Gross Profit | 4.63B | 47.09B | 4.39B | 5.60B | 4.55B | 3.52B |
| EBITDA | 1.97B | 1.76B | 1.50B | 2.51B | 1.67B | 883.00M |
| Net Income | 1.20B | 1.23B | 979.00M | 1.77B | 1.35B | 865.00M |
Balance Sheet | ||||||
| Total Assets | 15.10B | 16.11B | 15.21B | 15.74B | 13.99B | 12.36B |
| Cash, Cash Equivalents and Short-Term Investments | 5.66B | 5.67B | 6.60B | 9.82B | 10.71B | 9.10B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.79B | 2.38B | 2.19B | 2.85B | 2.29B | 1.73B |
| Stockholders Equity | 13.20B | 13.60B | 12.91B | 12.79B | 11.62B | 10.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 138.00M | -1.61B | 545.00M | 1.80B | 1.59B |
| Operating Cash Flow | 0.00 | 223.00M | -1.51B | 653.00M | 1.89B | 1.62B |
| Investing Cash Flow | 0.00 | -498.00M | -827.00M | -811.00M | 135.00M | -157.00M |
| Financing Cash Flow | 0.00 | -714.00M | -873.00M | -755.00M | -408.00M | -308.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥87.56B | 15.26 | 12.96% | 1.36% | 19.33% | 20.49% | |
71 Outperform | ¥544.93B | 14.85 | ― | 2.87% | 17.41% | 10.46% | |
68 Neutral | ¥11.13B | 9.40 | ― | 3.70% | -3.86% | 26.92% | |
66 Neutral | ¥11.71B | 6.69 | 11.46% | 4.65% | 9.55% | 40.52% | |
63 Neutral | ¥35.16B | 17.69 | ― | 3.02% | 8.81% | 11.05% | |
62 Neutral | ¥95.90B | 7.40 | ― | 2.41% | 50.28% | 79.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |